Geovax Labs (GOVX)

Positive Data From CM04S1 Phase 2 and Preclinical Trials


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
September 25, 2023
Report ID: 26116
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Geovax Labs
Geovax Labs
Healthcare
Biotechnology
Ticker
GOVX
Current Price
$1.74 2.96%
Market Cap
$4.0M
Price Target
Refer to Report
Volume
73.4K
52wk Range
$1.38 - $11.5365
Related Research Reports
5/15/2024

1Q24 Reported With Clinical Milestones Later In FY2024
1Q24 Reported With Clinical Milestones Later In FY2024 (GOVX)
3/7/2024

Vaccine Production Technology Reaches Milestone With Manufacturing Facility Validation
Vaccine Production Technology Reaches Milestone With Manufacturing Facility Validation (GOVX)
3/1/2024

FY2023 Reported With A Review Of Clinical Progress and Upcoming Milestones
FY2023 Reported With A Review Of Clinical Progress and Upcoming Milestones (GOVX)
2/7/2024

Initial Phase 2 Data Shows Immune Responses In COVID-19 Booster Trial
Initial Phase 2 Data Shows Immune Responses In COVID-19 Booster Trial (GOVX)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy